Syra Health Corp. Class A Common Stock
Market Cap
$1.09M
P/E Ratio
-1.20
EPS
$-0.08
Dividend Yield
0.00%
52-Week Range
$0.03 — $0.46
Volume
2.20K
Avg Volume
34.76K
Beta
4.33
Get alerted when SYRA hits your target price.
Free — enter your email to get started
P/E (TTM)
-1.20
Forward P/E
—
PEG Ratio
-0.10
P/S (TTM)
0.46
P/B (TTM)
1.65
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.39%
ROA (TTM)
-0.32%
ROIC
—
Gross Margin
0.30%
Operating Margin
-0.13%
Net Margin
—
Debt/Equity
0.07
Current Ratio
4.06
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-239.84%
EPS Growth (5Y)
-143.85%
Sales Growth (3Y)
+1.14%
Sales Growth (5Y)
+0.68%
EPS Est (This Year)
—
EPS Est (Next Year)
—
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.14
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
11.34M
Float
9.33M
Free Float %
82.26%
Sector
Healthcare
Industry
Medical - Care Facilities
Country
US
Exchange
NASDAQ
IPO Date
2023-09-29
Employees
57
CEO
Gregory R. Alexander
Index Membership
—
Website
https://www.syrahealth.com
Syra Health Corp. Class A Common Stock (SYRA) is a healthcare company in the medical - care facilities industry listed on the NASDAQ. With a market capitalization of $1.09M, a P/E ratio of -1.20, SYRA is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare SYRA against other stocks using dozens of fundamental and technical filters.
CCM
Concord Medical Services Holdings Limited
$3.95
+0.00%
$575.17K
MNDR
Mobile-health Network Solutions Class A Ordinary Shares
$0.95
+15.17%
$841.47K
PHA.V
Premier Health of America Inc.
$0.03
+0.00%
$1.39M
DHB.V
Delivra Health Brands Inc.
$0.15
+0.00%
$4.69M
IBO.V
Universal Ibogaine Inc.
$0.01
-50.00%
$1.56M
MTNB
Matinas BioPharma Holdings, Inc.
$0.70
+7.47%
$3.88M
Syra Health Corp. Class A Common Stock (SYRA) has a trailing twelve-month (TTM) P/E ratio of -1.20. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Syra Health Corp. Class A Common Stock (SYRA) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Syra Health Corp. Class A Common Stock (SYRA) has a market capitalization of $1.09 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.